• Something wrong with this record ?

Optimizing recombinant production of L-asparaginase 1 from Saccharomyces cerevisiae using response surface methodology

V. Ebrahimi, A. Hashemi

. 2024 ; 69 (6) : 1205-1219. [pub] 20240406

Language English Country Czech Republic

Document type Journal Article

Grant support
IR.SBMU.PHARMACY.REC.1401.037 Shahid Beheshti University of Medical Sciences

L-asparaginase is an essential enzyme used in cancer treatment, but its production faces challenges like low yield, high cost, and immunogenicity. Recombinant production is a promising method to overcome these limitations. In this study, response surface methodology (RSM) was used to optimize the production of L-asparaginase 1 from Saccharomyces cerevisiae in Escherichia coli K-12 BW25113. The Box-Behnken design (BBD) was utilized for the RSM modeling, and a total of 29 experiments were conducted. These experiments aimed to examine the impact of different factors, including the concentration of isopropyl-b-LD-thiogalactopyranoside (IPTG), the cell density prior to induction, the duration of induction, and the temperature, on the expression level of L-asparaginase 1. The results revealed that while the post-induction temperature, cell density at induction time, and post-induction time all had a significant influence on the response, the post-induction time exhibited the greatest effect. The optimized conditions (induction at cell density 0.8 with 0.7 mM IPTG for 4 h at 30 °C) resulted in a significant amount of L-asparaginase with a titer of 93.52 μg/mL, which was consistent with the model-based prediction. The study concluded that RSM optimization effectively increased the production of L-asparaginase 1 in E. coli, which could have the potential for large-scale fermentation. Further research can explore using other host cells, optimizing the fermentation process, and examining the effect of other variables to increase production.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24020983
003      
CZ-PrNML
005      
20241105105527.0
007      
ta
008      
241105s2024 xr f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-024-01163-2 $2 doi
035    __
$a (PubMed)38581537
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Ebrahimi, Vida $u Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, No. 2660, Valiasr-Niayesh Junction, Vali-e-Asr Ave, Tehran 1991953381, Iran
245    10
$a Optimizing recombinant production of L-asparaginase 1 from Saccharomyces cerevisiae using response surface methodology / $c V. Ebrahimi, A. Hashemi
520    9_
$a L-asparaginase is an essential enzyme used in cancer treatment, but its production faces challenges like low yield, high cost, and immunogenicity. Recombinant production is a promising method to overcome these limitations. In this study, response surface methodology (RSM) was used to optimize the production of L-asparaginase 1 from Saccharomyces cerevisiae in Escherichia coli K-12 BW25113. The Box-Behnken design (BBD) was utilized for the RSM modeling, and a total of 29 experiments were conducted. These experiments aimed to examine the impact of different factors, including the concentration of isopropyl-b-LD-thiogalactopyranoside (IPTG), the cell density prior to induction, the duration of induction, and the temperature, on the expression level of L-asparaginase 1. The results revealed that while the post-induction temperature, cell density at induction time, and post-induction time all had a significant influence on the response, the post-induction time exhibited the greatest effect. The optimized conditions (induction at cell density 0.8 with 0.7 mM IPTG for 4 h at 30 °C) resulted in a significant amount of L-asparaginase with a titer of 93.52 μg/mL, which was consistent with the model-based prediction. The study concluded that RSM optimization effectively increased the production of L-asparaginase 1 in E. coli, which could have the potential for large-scale fermentation. Further research can explore using other host cells, optimizing the fermentation process, and examining the effect of other variables to increase production.
650    12
$a asparaginasa $x genetika $x biosyntéza $x metabolismus $7 D001215
650    12
$a Saccharomyces cerevisiae $x genetika $x metabolismus $7 D012441
650    12
$a rekombinantní proteiny $x genetika $x metabolismus $7 D011994
650    _2
$a teplota $7 D013696
650    _2
$a isopropylthiogalaktosid $x farmakologie $7 D007544
650    _2
$a Escherichia coli K12 $x genetika $x enzymologie $7 D048168
650    _2
$a fermentace $7 D005285
650    _2
$a Escherichia coli $x genetika $x metabolismus $7 D004926
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hashemi, Atieh $u Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, No. 2660, Valiasr-Niayesh Junction, Vali-e-Asr Ave, Tehran 1991953381, Iran. atieh.hashemi.soltanieh@gmail.com $1 https://orcid.org/0000000171215306
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 69, č. 6 (2024), s. 1205-1219
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38581537 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241105 $b ABA008
991    __
$a 20241105105523 $b ABA008
999    __
$a ok $b bmc $g 2209300 $s 1232973
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 69 $c 6 $d 1205-1219 $e 20240406 $i 1874-9356 $m Folia microbiologica $n Folia Microbiol (Praha) $x MED00011005
GRA    __
$a IR.SBMU.PHARMACY.REC.1401.037 $p Shahid Beheshti University of Medical Sciences
LZP    __
$a Pubmed-20241105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...